Genus (GNS) Competitors GBX 2,611.27 +71.27 (+2.81%) As of 11:58 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock GNS vs. HWDN, DPH, IGG, CTY, SMWH, KYGA, CAR, PRP, AUK, and STGShould you be buying Genus stock or one of its competitors? The main competitors of Genus include Howden Joinery Group (HWDN), Dechra Pharmaceuticals (DPH), IG Group (IGG), City of London (CTY), WH Smith (SMWH), Kerry Group (KYGA), Carclo (CAR), Prime People (PRP), Aukett Swanke Group (AUK), and Strip Tinning (STG). These companies are all part of the "personal services" industry. Genus vs. Its Competitors Howden Joinery Group Dechra Pharmaceuticals IG Group City of London WH Smith Kerry Group Carclo Prime People Aukett Swanke Group Strip Tinning Genus (LON:GNS) and Howden Joinery Group (LON:HWDN) are both personal services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends. Do institutionals and insiders believe in GNS or HWDN? 63.4% of Genus shares are held by institutional investors. Comparatively, 67.4% of Howden Joinery Group shares are held by institutional investors. 0.7% of Genus shares are held by insiders. Comparatively, 0.9% of Howden Joinery Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor GNS or HWDN? In the previous week, Howden Joinery Group had 2 more articles in the media than Genus. MarketBeat recorded 4 mentions for Howden Joinery Group and 2 mentions for Genus. Genus' average media sentiment score of 1.11 beat Howden Joinery Group's score of 0.43 indicating that Genus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genus 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Howden Joinery Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is GNS or HWDN a better dividend stock? Genus pays an annual dividend of GBX 0.32 per share and has a dividend yield of 0.0%. Howden Joinery Group pays an annual dividend of GBX 0.21 per share and has a dividend yield of 0.0%. Genus pays out 110.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Howden Joinery Group pays out 45.8% of its earnings in the form of a dividend. Howden Joinery Group is clearly the better dividend stock, given its higher yield and lower payout ratio. Which has preferable earnings and valuation, GNS or HWDN? Howden Joinery Group has higher revenue and earnings than Genus. Howden Joinery Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenus£672.80M2.57£7.87M£0.299,035.53Howden Joinery Group£2.35B1.89£253.42M£0.461,775.90 Which has more volatility & risk, GNS or HWDN? Genus has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500. Comparatively, Howden Joinery Group has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Do analysts rate GNS or HWDN? Genus currently has a consensus price target of GBX 2,900, suggesting a potential upside of 11.06%. Howden Joinery Group has a consensus price target of GBX 919.67, suggesting a potential upside of 11.85%. Given Howden Joinery Group's higher possible upside, analysts clearly believe Howden Joinery Group is more favorable than Genus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Howden Joinery Group 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is GNS or HWDN more profitable? Howden Joinery Group has a net margin of 10.82% compared to Genus' net margin of 1.18%. Howden Joinery Group's return on equity of 25.70% beat Genus' return on equity.Company Net Margins Return on Equity Return on Assets Genus1.18% 1.41% 3.31% Howden Joinery Group 10.82%25.70%10.70% SummaryHowden Joinery Group beats Genus on 13 of the 18 factors compared between the two stocks. Get Genus News Delivered to You Automatically Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GNS vs. The Competition Export to ExcelMetricGenusBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.73B£231.79M£6.14B£2.61BDividend Yield1.26%3.80%5.66%5.28%P/E Ratio9,035.5396.9485.844,440.52Price / Sales2.576,073.88621.60100,568.44Price / Cash50.5613.1938.3227.90Price / Book3.15113.4713.068.88Net Income£7.87M-£90.99M£3.30B£5.89B7 Day Performance3.62%3.98%4.81%0.81%1 Month Performance-3.11%6.29%9.99%5.86%1 Year Performance21.26%725.82%85.28%154.98% Genus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GNSGenus1.7243 of 5 starsGBX 2,611.27+2.8%GBX 2,900+11.1%+23.3%£1.73B£672.80M9,035.53480Gap DownHWDNHowden Joinery Group1.9072 of 5 starsGBX 838.50+0.2%GBX 919.67+9.7%-6.7%£4.55B£2.35B1,811.0212,000DPHDechra PharmaceuticalsN/AN/AN/AN/A£4.40B£761.50M-15,464.002,457IGGIG Group3.9069 of 5 starsGBX 1,065+0.4%GBX 1,470.67+38.1%+18.4%£3.71B£949.10M1,013.322,754Insider TradeCTYCity of LondonN/AGBX 502-0.6%N/A+18.8%£2.49B£222.11M1,135.75N/ADividend AnnouncementSMWHWH Smith2.5018 of 5 starsGBX 673.85-0.6%GBX 998.20+48.1%-53.5%£839.35M£1.94B14,974.4414,935Dividend IncreaseKYGAKerry GroupN/AGBX 76-2.1%N/A-16.5%£123.76M£6.97B17.3021,000Gap DownCARCarcloN/AGBX 57.62-1.3%N/A+103.7%£42.30M£121.22M4,801.501,059PRPPrime PeopleN/AN/AN/AN/A£8.15M£19.72M10.9813,100Gap DownAUKAukett Swanke GroupN/AN/AN/AN/A£5.46M£23.61M-6.3232,200Gap DownSTGStrip TinningN/AGBX 24+4.3%N/A-37.1%£4.37M£8.78M-123.904,060Gap DownHigh Trading Volume Related Companies and Tools Related Companies Howden Joinery Group Competitors Dechra Pharmaceuticals Competitors IG Group Competitors City of London Competitors WH Smith Competitors Kerry Group Competitors Carclo Competitors Prime People Competitors Aukett Swanke Group Competitors Strip Tinning Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:GNS) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genus plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.